Updates are available Correction dated 2019-08-02
Click to view Correction: https://doi.org/10.1186/s12920-019-0563-y
-
Authors
Frank, Mayu O.
Koyama, Takahiko
Rhrissorrakrai, Kahn
Robine, Nicolas
Utro, Filippo
Emde, Anne-Katrin
Chen, Bo-Juen
Arora, Kanika
Shah, Minita
Geiger, Heather
Felice, Vanessa
Dikoglu, Esra
Rahman, Sadia
Fang, Alice
Vacic, Vladimir
Bergmann, Ewa A.
Vogel, Julia L. Moore
Reeves, Catherine
Khaira, Depinder
Calabro, Anthony
Kim, Duyang
Lamendola-Essel, Michelle F.
Esteves, Cecilia
Agius, Phaedra
Stolte, Christian
Boockvar, John
Demopoulos, Alexis
Placantonakis, Dimitris G.
Golfinos, John G.
Brennan, Cameron
Bruce, Jeffrey
Lassman, Andrew B.
Canoll, Peter
Grommes, Christian
Daras, Mariza
Diamond, Eli
Omuro, Antonio
Pentsova, Elena
Orange, Dana E.
Harvey, Stephen J.
Posner, Jerome B.
Michelini, Vanessa V.
Jobanputra, Vaidehi
Zody, Michael C.
Kelly, John
Parida, Laxmi
Wrzeszczynski, Kazimierz O.
Royyuru, Ajay K.
Darnell, Robert B. https://orcid.org/0000-0002-5134-8088
-
Funding
Funding for this research was provided by:
IBM (NA, awarded to New York Genome Center)
National Center for Advancing Translational Sciences (UL1TR000043)
Emerald Foundation (NA)
National Cancer Institute (P30CA008748, awarded to MSKCC)
Howard Hughes Medical Institute (NA)
- License Information
-
More Information
Article History
Received: 11 September 2018
Accepted: 28 March 2019
First Online: 25 April 2019
Change Date: 2 August 2019
Change Type: Correction
Change Details: Following publication of the original article [1], it was reported that the given name of the fourteenth author was incorrectly published. The incorrect and the correct names are given below.
Ethics approval and consent to participate
: All participants provided written informed consent to participate. Protocols were approved by local or central Institutional Review Boards at: Rockefeller University, Biomedical Research Alliance of New York (on behalf of Northwell Health), Memorial Sloan Kettering Cancer Center, New York University School of Medicine, and Weill Cornell Medicine.
: Not applicable.
: MOF and RBD received consultant fees from New York Genome Center. TK, KH, and FU have patent applicatons related to Watson for Genomics, no. 14/745616. VV owns stock and options in 23andMe, Inc. MFLE received consultant fees from Rockefeller University. ABL in the past 12 months, received personal compensation (consulting fees/honoraria) from Northwest Biotherapeutics, AbbVie, Agios, Bioclinica, Sapience, WebMD, NCI; travel support from Karopharm, Northwest Biotherapeutics, Oncoceutis, Global Coalition for Adaptive Research, New York University, Agios, Abbvie, Celgene, Novocure, NRG Oncology Foundation, Tocagen, and Yale University; and research support (to the institution) from NCI, Oncoceutics, AbbVie, Karyopharm, Beigene, VBI Vaccines, Kadmon, Pfizer, RTOG-Foundation, Aeterna Zentaris, Northwestern University, Novartis, Pfizer, Celldex, Millenium, UCLA, and Amgen. NR, AKE, BJC, KA, MS, HG, VF, ED, SR, AF, EAB, JLMV, CR, DKhaira, AC, DKim, CE, PA, CS, JB, AD, DGP, JGG, CB, JF, PC, CG, MD, ED, AO, EP, DEO, SJH, JBP, VVM, VJ, MCZ, JK, LP, KOW and AKR declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
